Ironwood Pharmaceuticals ... (IRWD)
1.42
-0.04 (-2.74%)
At close: Mar 28, 2025, 3:59 PM
1.42
0.13%
After-hours: Mar 28, 2025, 07:50 PM EDT
Ironwood Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -1B | 175.06M | 528.45M | 106.18M | 21.5M | -282.37M | -116.94M | -81.71M | -142.67M | -189.62M | -272.81M | -72.62M | -64.85M | -56.41M | -73.31M | -55.03M | -53.16M | -37.18M |
| Depreciation & Amortization | 1.57M | 1.42M | 1.52M | 3.56M | 5.58M | 14.22M | 14.62M | 11.26M | 11.63M | 12.33M | 11.73M | 11.32M | 10M | 6.16M | 5.25M | 2.85M | 1.73M | 1.26M |
| Stock-Based Compensation | 32.01M | 27.05M | 22.28M | 31.18M | 31.28M | 43.98M | 33.82M | 29.22M | 25.47M | 26.18M | 19.83M | 17.57M | 11.73M | 7.5M | 5.24M | 2.79M | 1.15M | n/a |
| Other Working Capital | -2.02M | 2.94M | 12.66M | 1.84M | 875K | -842K | 2.01M | -15.63M | -11.66M | -4.77M | -10.32M | -43.79M | -42.98M | -17.08M | 55.39M | 2.27M | 69.52M | 3.02M |
| Other Non-Cash Items | 1.07B | 1.67M | 25.21M | 22.26M | 16.42M | -13.44M | -16.81M | 28.12M | 8.4M | 4.14M | 1.72M | 1.18M | 2.23M | 1.62M | -360K | 532K | -1.72M | 249K |
| Deferred Income Tax | 72.64M | 65.74M | -333.29M | 6.6M | 35.93M | 159.11M | 7.53M | -7.31M | 28.48M | 21.5M | 1.86M | n/a | 7K | -5.5M | 970K | -1K | -1K | n/a |
| Change in Working Capital | 11.28M | 2.82M | 17.73M | -941K | -99.99M | 7.62M | -21.79M | -5.02M | -38.24M | -30.1M | -35.68M | -27.08M | -34.36M | -21.27M | 58.21M | 20.66M | 45.24M | 2.14M |
| Operating Cash Flow | 183.43M | 273.76M | 261.89M | 168.84M | 10.72M | -70.88M | -99.56M | -25.43M | -106.93M | -155.57M | -273.36M | -69.63M | -75.24M | -67.9M | -4M | -28.2M | -6.76M | -33.53M |
| Capital Expenditures | -273K | -136K | -265K | -1.84M | -7.19M | -8.62M | -4.21M | -104.21M | -4.05M | -3.54M | -9.59M | -13.98M | -9.68M | -17.22M | -4.04M | -22.93M | -2.65M | -2.82M |
| Acquisitions | -1.03B | n/a | n/a | n/a | 268K | 1.56M | 135K | 100M | 147K | n/a | n/a | n/a | n/a | 9.5M | n/a | n/a | n/a | 1K |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -3.24M | -191.35M | -311.12M | -281.96M | -254M | -287.94M | -96.71M | -97.51M | -441.8M | -26.67M | -82.61M | -87.84M | -36.99M |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 99.17M | 346.89M | 237.42M | 276.71M | 200.96M | 196.1M | 140.76M | 222.25M | 236.47M | 48.45M | 90.47M | 62.88M | 34.2M |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | -4.22M | 1.56M | 135K | -99.78M | 147K | -53.03M | -91.84M | 9K | 4K | 2K | 21K | 9K | 1K | n/a |
| Investing Cash Flow | -1.03B | -136K | -265K | -1.84M | -11.14M | 88.87M | 151.46M | -177.67M | -9.15M | -56.57M | -101.43M | 30.08M | 115.06M | -213.04M | 17.76M | -15.07M | -27.61M | -5.62M |
| Debt Repayment | 300M | -120.7M | n/a | n/a | 7.2M | -1.82M | 8.76M | -28.77M | 321.67M | -2.23M | 174.23M | -275K | -260K | -1.96M | 1.14M | -1.22M | 720K | -1.94M |
| Common Stock Repurchased | n/a | -126.39M | -24.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -22.84M | 9.54M | 19.58M | 18.55M | -8.39M | 31.9M | 11.08M | 24.59M | -18.6M | 22.74M | 1.58M | 4.02M | 3.39M | 1.75M | 40.52M | 49.78M | 50M | 7M |
| Financial Cash Flow | 277.16M | -237.55M | -4.55M | 18.55M | -1.19M | 30.07M | 19.84M | -4.18M | 303.07M | 210.94M | 313.58M | 88.97M | 3.13M | 202.96M | 41.66M | 48.56M | 50.72M | 80.09M |
| Net Cash Flow | -565.78M | 36.07M | 257.08M | 185.54M | -1.6M | 48.06M | 71.73M | -207.28M | 186.99M | -1.19M | -61.21M | 49.42M | 42.96M | -77.98M | 55.42M | 5.29M | 16.35M | n/a |
| Free Cash Flow | 183.15M | 273.63M | 261.63M | 166.99M | 3.54M | -79.5M | -103.77M | -129.64M | -110.98M | -159.11M | -282.95M | -83.61M | -84.92M | -85.12M | -8.04M | -51.13M | -9.41M | -36.35M |